Chief executive Pascal Soriot said AstraZeneca faced a “transitional period” due to the expiry of Crestor’s US patent in May, but the company was poised for a comeback and it would continue to plough investment into drug research

AstraZeneca warned on Thursday that revenue and earnings would drop this year due to the arrival of cheap generic rivals to Crestor, its top-selling c(...)

AstraZeneca agreed to buy a 55 per cent stake in Acerta Pharma for $4 billion to gain a potential blockbuster cancer medicine.

AstraZeneca agreed to buy a 55 per cent stake in Acerta Pharma for $4 billion to gain a potential blockbuster cancer medicine. The UK’s second-large(...)

AstraZeneca chief executive Pascal Soriot: ‘This acquisition complements our strategic focus on cardiovascular and metabolic disease.’ Photograph: Simon Dawson/Bloomberg

Britain’s AstraZeneca has agreed to buy US biotech company ZS Pharma for $2.7 billion, pipping Swiss firm Actelion to the prize in the latest bout of (...)

Bottles of AstraZeneca’s Nexium heartburn medication. Photographer: Daniel Acker/Bloomberg

AstraZeneca, the second-largest UK drug maker, said fourth-quarter earnings fell 33 per cent as revenue declined for two of its best-selling drugs and(...)

The company’s work on immune-boosting cancer treatments is advancing especially fast, chief executive Pascal Soriot said. Photograph: Bloomberg

AstraZeneca touted an “industry-leading” line-up of hot new cancer drugs as it looked to show investors it has a strong independent future just days b(...)

Christopher Viehbacher, ousted chief executive officer of French pharma group Sanofi. Photographer: Scott Eells/Bloomberg

Sanofi investors said former chief executive Chris Viehbacher, ousted today, paid the price for pushing too hard to make the French drugmaker more int(...)

 AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach from rival Pfizer two months ago. Photo: Bloomberg

AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach fr(...)

Online grocery group Ocado is set to make its first annual profit since being set up by three former Goldman Sachs bankers in 2000.

It’s taken almost a decade and a half but, at last, online grocery group Ocado is set to make its first annual profit since being set up by three form(...)

AstraZeneca chief executive Pascal Soriot will address a cancer conference in Chicago. Photograph: Luke MacGregor/Reuters

AstraZeneca will this week attempt to show investors why it rejected Pfizer’s near-£70 billion takeover offer as its chief executive flies to the Uni(...)

PFIZER’S £69 billion bid for AstraZeneca may be dead in the water, for now at least, but the Anglo-Swedish pharmaceuticals giant has some hard work ah(...)